期刊文献+

肿瘤特异性生长因子和甲状腺球蛋白联合检测诊断甲状腺癌的临床应用 被引量:3

Clinical application of joint detection of tumor-specific growth factors and thyroglobulin in the diagnosis of thyroid cancer
暂未订购
导出
摘要 目的研究肿瘤特异性生长因子(TSGF)和甲状腺球蛋白(Tg)联合检测诊断甲状腺癌的临床应用价值。方法 74例经病理证实的甲状腺癌患者(甲状腺癌组)和69例志愿者(正常组),使用德国IBL International公司的试剂盒检验肿瘤特异性生长因子和甲状腺球蛋白。采用统计学方法对两组的实验结果进行分析。结果正常组和甲状腺癌组之间的比较具有可行性且指标检验的准确度和精密度较高。TSGF和Tg在正常组和甲状腺癌组间的差异具有统计学意义(P<0.05),后者的水平均较高。TSGF、Tg与甲状腺癌组相关性明显(P<0.05)。TSGF、Tg以及Tg/TSGF的ROC曲线下面积均大于0.90,对甲状腺癌的诊断价值排序为:Tg/TSGF>Tg>TSGF。结论 Tg/TSGF对甲状腺癌有较高的诊断价值。 Objective -To study the clinical value of joint detection of tumor-specific growth factors (TSGF) and thyroglobulin (Tg) in the diagnosis of thyroid cancer. Methods TSGF and Tg were tested within 74 patients patho- logically confmned as thyroid cancer (the study group) and 69 volunteers (the control group), using kits fi'om the Ger- man IBL International. Appropriate statistical methods were used to analyze the experimental results. Results Compar- ison between the control group and the study group was feasible, with high accuracy and precision. TSGF and Tg lev- els showed statistically significant difference between the study group and the control group (P〈0.05), which were sig- nificantly higher in the study group. TSGF and Tg levels were significantly related to thyroid cancer (P〈0.05). Area under the curve of TSGF, Tg and Tg/TSGF were greater than 0.90, so the diagnosis values ofTSGF, Tg and Tg/TSGF were very high: Tg/TSGF〉Tg〉TSGF. Conclusion Joint detection of TSGF and Tg has high value in the diagnosis of thyroid cancer.
作者 杨军
出处 《海南医学》 CAS 2013年第15期2266-2268,共3页 Hainan Medical Journal
关键词 肿瘤特异性生长因子 甲状腺球蛋白 甲状腺癌 诊断 Tumor-specific growth factor (TSGF) Thyroglobulin (Tg) Thyroid cancer Diagnosis
  • 相关文献

参考文献13

  • 1Rego-Iraeta A, Perez-Mendez LF, Mantinan B, et al. Time trends for thyroid cancer in northwestern Spain: true rise in the incidence of micro and larger forms of papi\lary thyroid carcinoma[J]. Thyroid, 2009, 19(4): 333-40.
  • 2Yuksel 0, Kurukahvecioglu 0, Ege B, et al. The relation between pure papi\lary and follicular variant in papi\lary thyroid carcinoma[J]. Endocr Regul, 2008, 42(1): 29-33.
  • 3徐向东,王海鹏.健康体检人群恶性肿瘤特异性生长因子的检测与分析[J].标记免疫分析与临床,2010,17(3):190-191. 被引量:5
  • 4Pacini F, Sabra MM, Tuttle RM. Clinical relevance of thyroglobulin doubling time in the management of patients with differentiated thy?roid cancer[J]. Thyroid, 2011, 21(7): 691-692.
  • 5Albrecht AM, Paulson CP, Kovach FE. Clinical inquiries. What's the best way to monitor low-risk patients with a history of differentiat?ed thyroid cancer?[J]. J Fam Pract, 2009, 58: E4.
  • 6罗家伦,徐慧琴,赵学峰,岳峤,汪会.甲状腺球蛋白及抗甲状腺球蛋白抗体联合颈部超声在分化型甲状腺癌复发或转移灶诊断中的价值[J].中华临床医师杂志(电子版),2012,6(3):32-35. 被引量:18
  • 7Park YJ, Kwak SH, Kim DC, et al. Diagnostic value of galectin-3, HBME-l, cytokeratin 19, high molecular weight cytokeratin, cyelin Dl and p27(kipl) in the differential diagnosis of thyroid nodules[J]. J Korean Med Sci, 2007, 22: 621-628.
  • 8Sapio MR, Guerra A, Posca D, et al. Combined analysis of galee?tin-3 and BRAFV600E improves the accuracy of fine-needle aspira?tion biopsy with cytological findings suspicious for papi\lary thy?roid carcinoma[J]. Endocr Relat Cancer, 2007, 14: 1089-1097.
  • 9Liu YY, Morreau H, Kievit J, et al. Combined immunostaining with galectin-3, fibronectin-l, CITED-I, Hector Battifora mesotheli?al-I, cytokerann-Is, peroxisome proliferator-activated recep?tor-{garnma}, and sodium/iodide symporter antibodies for the differ?ential diagnosis of non-medullary thyroid carcinoma[J]. Eur J En?docrinol,2008, 158: 375-384.
  • 10孟彦,吴雨雷,武乃旺,史克俊,高太虎.血清肿瘤特异性生长因子检测对甲状腺癌的诊断价值[J].山西职工医学院学报,2010,20(1):6-7. 被引量:11

二级参考文献23

共引文献32

同被引文献29

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部